Biotechnology

Moleculin Biotech Inc (NASDAQ: MBRX) has announced preliminary results supporting the successful conclusion of its second Phase 1 trial in Poland, evaluating Annamycin for relapsed and refractory acute myeloid leukemia (AML). Moleculin determined a dose of 240 mg/m2 as the...

Neurocrine Biosciences Inc (NASDAQ: NBIX) reported Q4 Ingrezza sales of $301 million, +25% Y/Y, with total prescriptions up 32% Overall sales increased $312.0 million 26%, missing the consensus of $316.79 million. Ingrezza (valbenazine) is indicated for adults with movements in the face...

The FDA has signed off Turning Point Therapeutics Inc's (NASDAQ: TPTX) Investigational New Drug (IND) application for elzovantinib + aumolertinib combo therapy in EGFR mutant MET-amplified advanced non-small cell lung cancer (NSCLC).  The Company expects to initiate the...

Keybanc raised J.B. Hunt Transport Services, Inc. (NASDAQ: JBHT) price target from $210 to $225. J.B. Hunt shares fell 0.1% to $202.00 in pre-market trading. Raymond James cut Construction Partners, Inc. (NASDAQ: ROAD) price target from $35 to $30. Construction Partners shares rose 0.3% to...

Gainers Nutriband Inc. (NASDAQ: NTRB) shares jumped 120.2% to $8.61 after the company announced the Korean Intellectual Property Office has fully issued its patent titled "Abuse and Misuse Deterrent Transdermal System" which is related to the company's lead technology AVERSA....

Pre-open movers U.S. stock futures traded slightly lower in early pre-market trade on the final trading day of 2021. The Dow Jones dropped around 90 points, snapping a six-session winning streak on Thursday. US initial jobless claims dropped by 8,000 from the prior period to 198,000 in the week...

Some of the stocks that may grab investor focus today are: Medalist Diversified REIT, Inc. (NASDAQ: MDRR) reported a stock repurchase program of 500,000 shares. Medalist Diversified shares climbed 22.6% to $1.25 in the after-hours trading session. Lexicon Pharmaceuticals (NASDAQ: LXRX) said it...

Neurocrine Biosciences Inc (NASDAQ: NBIX) revealed topline data from its Phase 3 KINECT-HD study evaluating Ingrezza (valbenazine) for chorea associated with Huntington's disease (HD).  The selective vesicular monoamine transporter 2 (VMAT2) inhibitor is being investigated...

Roth Capital notes that the FDA cleared Moleculin Biotech Inc's (NASDAQ: MBRX) WP1122 to start a Phase 1 trial in glioblastoma multiforme, which will be in addition to the drug's impending parallel clinical development in COVID-19.  Analyst Jonathan Aschoff expects...

Neurocrine Biosciences Inc (NASDAQ: NBIX) has outlined a deal that provides Sosei Heptares Corporation $100 million upfront, R&D expenses, and a motherlode of milestones worth up to $2.6 billion if successful.  Under the terms of the agreement, Neurocrine...

Gainers Sono Group N.V. (NASDAQ: SEV) shares climbed 154.7% to close at $38.20 on Wednesday after the company priced its IPO at $15 per share. Braze, Inc. (NASDAQ: BRZE) jumped 43.7% to settle at $93.39 after the company priced its IPO at $65 per share. EyePoint Pharmaceuticals, Inc. (NASDAQ:...

Gainers Sono Group N.V. (NASDAQ: SEV) shares jumped 66% to $24.90 after the company priced its IPO at $15 per share. EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) shares climbed 23.1% to $17.29. EyePoint Pharmaceuticals priced an underwritten public offering of 4.03 million at $13.75 per share...

Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) has announced a new analysis evaluating the benefit of sotagliflozin in heart failure and blood glucose control across the full range of kidney function. In the new analysis of pooled data from the SOLOIST and SCORED trials, sotagliflozin...

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced plans to split into two separate publicly traded companies.  One company will feature the OmniAb business, and the other housing Ligand’s existing royalties and technologies, including its Pelican protein expression...

Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares jumped 95.1% to close at $12.68 on Thursday after dropping over 10% on Wednesday. TDH Holdings, Inc. (NASDAQ: PETZ) jumped 79.8% to settle at $4.26 after the company entered into a securities purchase agreement with certain investors for a...